Abacus Medicine - Original European Supply

Abacus Medicine plans Initial Public Offering on the Frankfurt Stock Exchange

Abacus Medicine is a business. We operate commercially, and our activities provide jobs, careers and livelihoods for hundreds of people in dozens of countries.

But we are more than that. When we compete in the market, we help lower prices on life-critical medicines so that they become more widely available. This gives us a purpose beyond ourselves and is something we can be proud of.

Flemming Wagner

CEO & majority shareholder

Abacus Medicine is a family business. The company was established in 2004 by CEO Flemming Wagner and his father, Medical Director John Wagner. We have grown ever since. Today, you will find our offices and our 500 people in a number of countries.

Our business model is based on the core principle of the free movement of goods in the EU’s single market. We invest heavily in entering new markets and in increasing the number of medicines that we hold a license to sell. Advanced IT systems for analysing Big Data in real time make us frontrunners in our industry.

Partner Solutions

Abacus Medicine is part of a large and constantly growing network. We serve as a trusted partner for knowledge and information.

Customers

Abacus Medicine is a valued business partner for leading wholesalers, hospitals, and pharmacies throughout Europe.

Suppliers

Our sourcing and supply network reaches reputable business partners all over Europe. We value long-term relationships.

Working at Abacus

I currently work as a QA Officer, and my primary job is to ensure patient safety. To do this, I ensure that the processes at the manufacturing site are in line with legislation and GMP regulations, and I play an active role in developing and improving quality assurance processes. For me, Abacus offers opportunity for development, stability and a secure future.